Ignite Creation Date:
2025-12-24 @ 3:49 PM
Ignite Modification Date:
2026-01-01 @ 6:45 AM
Study NCT ID:
NCT00456092
Status:
COMPLETED
Last Update Posted:
2020-06-19
First Post:
2007-04-02
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Phase II Study of Apremilast (CC-10004) in Adults With in Psoriatic Arthritis
Sponsor:
Amgen
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
CC-10004-PSA-001
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None